Skip to main content
. 2024 Mar 19;47(9):2269–2277. doi: 10.1007/s40618-024-02321-6

Table 2.

Individual hormonal and radiological data of patients, both cured and partially cured at first follow-up, who showed recurrence of disease after surgery

Sex Age at diagnosis After TNS surgery At time of recurrence MRI imaging at follow-up Time of recurrence (months after TNS)
Patients cured at first follow-up after surgery
1 M 59

IGF1 -0.15 SDS

GHn 0.09 µg/L

IGF1 5.61 SDS

GHn 1.27 µg/L

Stable residual tumor 15
2 F 23

IGF1 0.93 SDS

GHn 0.06 µg/L

IGF1 5.07 SDS

GHn 0.18 µg/L

Empty sella 157.8
3 M 50

IGF1 1.12 SDS

GHn 0.20 µg/L

IGF1 3.85 SDS

GHn 0.16 µg/L

Stable residual tumor 134
4 M 41

IGF1 0.26 SDS

GHr 0.8 µg/L

IGF1 4.72 SDS

GHn 0.50 µg/L

Stable residual tumor 28
5 F 36

IGF1 -0.40 SDS

GHn 0.11 µg/L

IGF1 3.25 SDS

NA

NA 5
Patients partially cured at first follow-up after surgery
6 F 47

IGF1 2.01 SDS

GHn 0.47 µg/L

IGF1 2.75 SDS

GHn 0.60 µg/L

Empty sella 12
7 M 74

IGF1 0.76 SDS

GHn 2.20 µg/L

IGF1 3.62 SDS

GHn 0.50 µg/L

Stable residual tumor 37